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ABSTRACT             
      The present study was carried out in the Department of Biochemistry, 
Faculty of Veterinary Medicine, University of Khartoum, to investigate and 
compare immunological and histopathological findings in Wistar albino rats 
fed high cholesterol diet versus another group fed saturated fats diet. 
       Thirty rats of both sexes (14 -16 weeks old) were divided into three 
equal groups: A, B and C of ten rats each and fed for three months as 
follows: Group A (control group) fed normal rats’ basal diet. Group B was 
given cholesterol powder mixed as 2% of the rats’ basal diet. Group C was 
fed cow tallow rich in saturated fats mixed with the normal basal rats’ diet 
as 14% of the diet. 
         Blood samples were collected from the first of August up to the end of 
October 2008, analyzed by ELISA techniques for the concentration of the 
oxidized LDL cholesterol, antibodies (IgG and IgM), and the total and 
differential count of white blood cells. The total protein, albumin and 
globulins concentrations were also determined. The histopathological 
changes were recorded for heart and liver of all rats at the end of the 
experiment.    
          The concentration of plasma total protein showed significant (P< 
0.05) increase in group B and group C compared with group A after three 
months, and no significant difference between group B and group C was 
observed.  
            A significant (P<0.05) decrease in the levels of the plasma albumin 
concentration was showed by group C compared with groups A and B, after 
the first and second months of treatment but the level in this group reached a 
similar level to the other groups after the three months of the study. 
x 
 
 
             The serum total globulins concentration was significantly (P<0.05) 
more in groups B and C obtained than in group A (the control), with no 
significant difference between months of group B and group C.   
           The total white blood cells count and the differential count showed 
no significant differences between the treated groups or the control group. 
This was also true for the total count of white blood cells, lymphocytes, 
basophiles, monocytes and the eosinophiles. Only the neutrophiles showed 
significant (P<0.05) decrease in group B compared with group A. 
         After three months, the Levels of the oxidized LDL cholesterol 
antibodies, in (IgG and IgM) showed no significant difference between 
groups A and B. Only the group receiving diet high in saturated fats (group 
C) showed significantly (P<0.05) higher level than the other groups. 
               Histopathological findings indicated that both high dietary 
cholesterol and high dietary saturated fats resulted in clear histopathological 
changes in tissues of the heart and liver of B and C groups with more 
inflammatory lesions in the tissues of group C.  
                The significant increase in the total globulin’s levels and the 
oxLDL antibodies together with the histopathological changes in the treated 
groups are an indication of great immunological changes. Further detailed 
studies in the related cytokines and the oxLDL will give an explanation of 
these findings. The study also highlighted the danger of feeding high 
saturated fats diet in comparison with feeding high cholesterol diet, though 
both showed adverse effects in the experimental animals. 
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  اﻟﻤﺴﺘﺨﻠﺺ
آﻠﻴﺔ اﻟﻄﺐ اﻟﺒﻴﻄﺮي، ﺟﺎﻣﻌﺔ اﻟﺨﺮﻃﻮم،  ،ﺟﺮﻳﺖ هﺬﻩ اﻟﺪراﺳﺔ ﻓﻲ ﻗﺴﻢ اﻟﻜﻴﻤﻴﺎء اﻟﺤﻴﻮﻳﺔأ       
ﻧﺴﺠﺔ اﻟﻤﺮﻳﻀﻪ ﻋﻠﻲ ﺟﺮذان وﺳﺘﺮ اﻟﺒﻴﻀﺎء اﻟﺘﻲ اﻟﻤﻨﺎﻋﺔ وأﻻاﻟﺘﻐﻴﻴﺮات ﻋﻠﻲ ﻟﺘﺤﺮي وﻣﻘﺎرﻧﺔ 
  .اﻟﺪهﻮن اﻟﻤﺸﺒﻌﺔ ﻓﻲ ﻏﺬاﺋﻬﺎ ﺧﺮي ﺗﻨﺎوﻟﺖًء ﻋﺎل اﻟﻜﻮﻟﺴﺘﻴﺮول ﻣﻘﺎﺑﻞ ﻣﺠﻤﻮﻋﺔ ٔاﺗﻨﺎوﻟﺖ ﻏﺬا
ﺳﺒﻮﻋًﺎ ﻋﻠﻲ ﺛﻼث ﻣﺠﻤﻮﻋﺎت ٔا  61و  41ﻣﺎ ﺑﻴﻦ    ﻢﻋﻤﺎرهٔا ،ﺛﻼﺛﻮن ﺟﺮذًا ﻣﻦ اﻟﺠﻨﺴﻴﻦ ﻗﺴﻢ 
  :ﻬﺎ ﻟﺜﻼﺛﺔ اﺷﻬﺮ آﺎْﻻﺗﻲﺋواﻟﺘﻲ ﺗﻨﺎوﻟﺖ ﻏﺬا ﻋﺸﺮة ﺟﺮذان ﻟﻜﻞٍِ ، ج و ب   أ، ﻣﺘﺴﺎوﻳﺔ 
ﻋﻄﻴﺖ اﻟﻤﺠﻤﻮﻋﺔ ب ٔا وﺳﺎﺳﻲ ﻋﻄﻴﺖ ﻏﺬاء اﻟﺠﺮذان أﻻؤاآﺸﺎهﺪ ﺘﺨﺪﻣﺖ ﺳاﻟﻤﺠﻤﻮﻋﺔ أ ٔا        
% 41ﻋﻄﻴﺖ اﻟﻤﺠﻤﻮﻋﺔ ج ٔا وﺳﺎﺳﻲ ﻣﻦ ﻏﺬاء اﻟﺠﺮذان أﻻ% 2ﺑﻨﺴﺒﺔ  ﺔﺑﺪرة آﻠﺴﺘﺮول ﻣﺨﻠﻮﻃ
  .ﺳﺎﺳﻲ ﻟﻠﺠﺮذانﺷﺤﻢ ﺑﻘﺮي ﻏﻨﻲ ﺑﺎﻟﺪهﻮن اﻟﻤﺸﺒﻌﺔ ﺗﻢ ﺧﻠﻄﻪ ﺑﺎﻟﻐﺬاء أﻻ
ﺛﻢ ﺣﻠﻠﺖ ﺑﺘﻘﻨﻴﺎت ال   وﻣﻦ 8002 ﺑﺮاآﺘﻮ ﺟﻤﻌﺖ ﻋﻴﻨﺎت اﻟﺪم ﻣﻦ أول اﻏﺴﻄﺲ ﺣﺘﻲ ﻧﻬﺎﻳﺔ          
 (  MgIو )GgI ﻟﻜﻞ ﻣﻦ ال  LDLxoﺟﺴﺎم اﻟﻤﻀﺎدة ﻟﻠﻜﻮﻟﺴﺘﻴﺮولآﻴﺰ أﻻاﻟﺤﺴﺎب ﺗﺮ ASILE
 ،آﻴﺰ اﻟﺒﺮوﺗﻴﻦ واﻻﻟﺒﻴﻮﻣﻴﻦ واﻟﻘﻠﻮﺑﻠﻴﻦﺗﺮا ﺣﺴﺎب ،، اﻟﺤﺴﺎب اﻟﻜﻠﻲ واﻟﺘﻔﺮﻳﻘﻲ ﻟﻜﺮﻳﺎت اﻟﺪم اﻟﺒﻴﻀﺎء
  .ﺟﻤﻴﻊ اﻟﺠﺮذان ﻓﻲ ﻧﻬﺎﻳﺔ اﻟﺘﺠﺮﺑﺔﻧﺴﺠﺔ اﻟﻤﻤﺮﺿﻪ ﻟﻠﻘﻠﺐ واﻟﻜﺒﺪ ﻋﻠﻲ واﻟﺘﻌّـﺮف ﻋﻠﻲ ﺗﻐﻴﻴﺮات أﻻ
 ﻓﻲ )50.0<P(وﺿﺤﺖ ﻧﺘﺎﺋﺞ ﺗﺮآﻴﺰ اﻟﺒﺮوﺗﻴﻦ اﻟﻜﻠﻲ ﻓﻲ اﻟﺒﻼزﻣﺎ زﻳﺎدﻩ  ﻣﻌﻨﻮﻳﻪ ٔا       
  )50.0<P(ﺎﻟﻢ ﻳﺴﺠﻞ ﻓﺮق ﻣﻌﻨﻮﻳواﻟﻤﺠﻤﻮﻋﺔ أ ﺑﻌﺪ اﻟﺜﻼﺛﺔ أﺷﻬﺮ، ﻣﻊ ب و ج ﻣﻘﺎرﻧﺔ  ﺘﻴﻦاﻟﻤﺠﻤﻮﻋ
  .ب  و ج ﺘﻴﻦﺑﻴﻦ اﻟﻤﺠﻤﻮﻋ
ﻴﺰ اﻻﺑﻴﻮﻣﻴﻦ ﻓﻲ اﻟﺒﻼزﻣﺎ ﻓﻲ اﻟﻤﺠﻤﻮﻋﺔ ج ﻣﻘﺎرﻧﺔ ﻣﺴﺘﻮي ﺗﺮآ )50.0<P( ﺎﻣﻌﻨﻮﻳ ﻧﺨﻔﺾا       
، وﻟﻜﻦ ﻋﻠﻲ ﻣﺴﺘﻮي هﺬﻩ اﻷول واﻟﺜﺎﻧﻲ ﻣﻦ إﻋﻄﺎء اﻟﻤﻌﺎﻟﺞ أ و ب ﺑﻌﺪ اﻟﺸﻬﺮ ﺘﻴﻦاﻟﻤﺠﻤﻮﻋﻣﻊ 
  .ﺧﺮي ﺑﻌﺪ ﺛﻼﺛﺔ أﺷﻬﺮ ﻣﻦ اﻟﺪراﺳﺔﻟﻠﻤﺠﻤﻮﻋﺎت أﻻ ﻣﺸﺎﺑﻪ ﻣﺴﺘﻮي اﻟﻤﺠﻤﻮﻋﺔ ﺗﻢ اﻟﺘﻮﺻﻞ اﻟﻲ
ﻣﻊ ب و ج ﻣﻘﺎرﻧﺔ  ﺘﻴﻦاﻟﻤﺠﻤﻮﻋ ﻓﻲ )50.0<P( ﺎ ﻣﻌﻨﻮﻳ ارﺗﻔﻊ ﺗﺮآﻴﺰاﻟﻘﻠﻮﺑﻠﻴﻦ اﻟﻜﻠﻲ     
  . ب و ج ﺘﻴﻦﺑﻴﻦ اﻟﻤﺠﻤﻮﻋ  )50.0<P(ﻟﻢ ﻳﺴﺠﻞ ﻓﺮق ﻣﻌﻨﻮيو أ اﻟﻤﺠﻤﻮﻋﺔ
ﻋﻨﺪﻣﺎ ﻗﻮرﻧﺖ  ﺎﻣﻌﻨﻮﻳ ﺎاﻟﻤﺠﻤﻮع اﻟﻜﻠﻲ واﻟﺘﻤﻴﻴﺰي ﻟﺨﻼﻳﺎ اﻟﺪم اﻟﺒﻴﻀﺎء ﻟﻢ ﺗﺴﺠﻞ ﻓﺮﻗ        
ﻣﺠﻤﻮع ﻋﺪد وهﻲ ﺣﻘﻴﻘﺔ واﻗﻌﺔ ﻋﻠﻲ . اﻟﺘﺤﻜﻢو ﻣﻊ ﻣﺠﻤﻮﻋﺔ أاﻟﻤﺠﻤﻮﻋﺎت اﻟﻤﻌﺎﻟﺠﻪ ﻣﻊ ﺑﻌﻀﻬﺎ 
 ﺎﻇﻬﺮت ﻧﻘﺼٔاﻋﺪا اﻟﻌﺪﻻت اﻟﺘﻲ . ﺣﺎدﻳﻪ  واﻟﺤﻤﻀﻴﻪوأﻻ  واﻟﻘﺎﻋﺪﻳﻪ ﻼﻳﺎ اﻟﺪم اﻟﺒﻴﻀﺎء اﻟﻠﻤﻔﻴﻪﺧ
  . أ اﻟﻤﺠﻤﻮﻋﺔﻣﻊ ﻣﻘﺎرﻧﺔ   ب ﻓﻲ اﻟﻤﺠﻤﻮﻋﺔ  )50.0<P( ﺎﻣﻌﻨﻮﻳ
 ﻟﻜﻞ ﻣﻦ ال  LDLxo  ﺟﺴﺎم اﻟﻤﻀﺎدة ﻟﻠﻜﻮﻟﺴﺘﻴﺮولﻧﺘﺎﺋﺞ ﻣﺴﺘﻮي أﻻ وﺿﺤﺖﺑﻌﺪ اﻟﺜﻼﺛﺔ اﺷﻬﺮٔا    
أ ﻣﻊ ب ﻓﻲ هﺬﻩ  ﺘﻴﻦﻞ ﻓﺮق ﻣﻌﻨﻮي ﻋﻨﺪﻣﺎ ﻗﻮرﻧﺖ  اﻟﻤﺠﻤﻮﻋﻧﻪ ﻟﻢ ﻳﺴﺠٔا  MgI( و )GgI  
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ﻇﻬﺮت ٔا( اﻟﻤﺠﻤﻮﻋﺔ ج)ﻋﻄﻴﺖ ﻏﺬاًء ﻋﺎل ﺑﺎﻟﺪهﻮن اﻟﻤﺸﺒﻌﺔ  ﻓﻘﻂ اﻟﻤﺠﻤﻮﻋﺔ اﻟﺘﻲ ٔا. اﻟﺪراﺳﺔ
   .ﺧﺮياﻟﻤﺠﻤﻮﻋﺎت أﻻﻣﻊ ﻣﻘﺎرﻧﺔ  )50.0<P(ﻣﺴﺘﻮي أﻋﻠﻲ ﻣﻌﻨﻮﻳًﺎ 
هﻮن اﻟﻤﺸﺒﻌﺔ ﻓﻲ واﻟﺪاﻟﻤﺮﺗﻔﻊ اﻟﻜﻮﻟﺴﺘﻴﺮول ﻋﻠﻲ ﻧﺴﺠﺔ اﻟﻤﺮﻳﻀﻪ  ﻧﺘﺎﺋﺞ ﻓﺤﺺ أﻻ وﺿﺤﺖا     
إﻟﺘﻬﺎﺑﻴﻪ ﻓﻲ ﺧﻼﻳﺎ ﻧﺨﺮات ﻧﺴﺠﺔ اﻟﻘﻠﺐ واﻟﻜﺒﺪ ﻟﻜﻼ اﻟﻤﺠﻤﻮﻋﺘﻴﻦ ب وج ﻣﻊ اﻟﻐﺬاء ﺗﻐﻴﻴًﺮا ﻓﻲ ٔا
  .ج ﻟﻤﺠﻤﻮﻋﺔا
  LDLxoﺟﺴﺎم اﻟﻤﻀﺎدة ﻟﻠﻜﻮﻟﺴﺘﻴﺮولاﻟﻜﻠﻲ وأﻻ ﻣﺴﺘﻮي اﻟﻘﻠﻮﺑﻠﻴﻦ ﻋﻠﻲ ﻤﻌﻨﻮياﻷرﺗﻔﺎع اﻟ       
 ﺮ ﻣﻨﺎﻋﻲﻴاﻟﻲ ﺗﻐﻴﻗﺎدت ﺎﻟﺠﺔ ﻧﺴﺠﺔ اﻟﻤﺮﻳﻀﻪ ﻓﻲ اﻟﻤﺠﻤﻮﻋﺘﻴﻦ اﻟﻤﻌﻓﻲ أﻻ اتﺎﻟﺘﻐﻴﻴﺮﺑ  ﻣﺼﺤﻮﺑﺎ
وﺛﻴﻘﻪ  LDLxoو( senikotyC)ﻠﺴﺎﻳﺘﻮآﺎﻳﻦ ﺎت ﺗﻔﺼﻴﻠﻴﻪ ﻟدراﺳ اﺿﺎﻓﺔ وﺟﺐ وﻣﻦ هﻨﺎ. آﺒﻴﺮ
ن ﺗﻨﺎول ٔا  ﻟﻘﺖ اﻟﻀﻮء ﻋﻠﻲاﻟﺪراﺳﺔ ٔا .اﻟﺼﻠﻪ ﺑﻬﺬﻩ اﻟﺪراﺳﺔ ﻟﺘﻌﻄﻲ رؤﻳﻪ اآﺜﺮوﺿﻮﺣﺎ واﺷﺮا ﻗﺎ
ﻟﻨﻮﻋﻴﻦ اﻟﻲ اﻟﻮﺟﺒﺔ آﺜﺮ ﺧﻄﻮرﻩ  ﻣﻦ ﺗﻨﺎول اﻟﻜﻮﻟﺴﺘﻴﺮول اﻟﻌﺎﻟﻲ ﻣﻊ أن إﺿﺎﻓﺔ ااﻟﺪهﻮن اﻟﻤﺸﺒﻌﻪ ٔا
  .ﻋﻠﻲ ﺣﻴﻮاﻧﺎت اﻟﺘﺠﺎربوﻣﺪﻣﺮﻩ  ا ﺿﺎرﻩﺛﺎًرﻇﻬﺮت ٔاﺑﻨﺴﺒﺔ ﻋﺎﻟﻴﺔ ٔا
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Introduction 
 
            Lipids play many roles in biological systems. Like carbohydrates 
they are an important source of energy. They are essential components of 
membranes, they function as hormones, and they can serve as padding and 
thermal insulator.  Lipids are complex and heterogeneous groups of 
compounds that they defy rational classification.  However, despite their 
difference in structure, they share the property of being insoluble in water. 
Indeed they are so insoluble that they require special water-soluble lipid-
protein complex (lipoprotein) for transport in the blood stream (Murray et 
al., 2003). 
             Even though atherosclerosis is reaching epidemic proportions now 
days, it is not in any way a disease specific to modern times, and it was 
already present in antiquity. Sir Marc Ruffed was able to identify in 1911 
degenerative arterial changes suggestive of atherosclerosis in the left 
subclavian artery from an Egyptian mummy. The term atheroma, derived 
from Greek and meaning porridge was first proposed by Albrecht von 
Haller in 1755 to designate the degenerative process observed in the intima 
of arteries (Ross, 1993). 
        Many researchers have suggested that the blood lipids play a key role 
in the immune defense system (Gallin et al., 1996). There is also a growing 
understanding that an inflammatory response of the arterial intima to injury 
is a crucial step in the genesis of atherosclerosis. And those infections may 
be one type of such injury (Ross, 1986). These two concepts are difficult to 
harmonize with the low-density-lipoprotein (LDL) receptor hypothesis, 
according to which high LDL cholesterol is the most important cause of 
atherosclerosis. However, the many observations that conflict with the LDL 
receptor hypothesis may be explained by the idea that high serum 
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cholesterol and/or high LDL are protective against infection and 
atherosclerosis. Diets high in saturated fat are correlated with an increased 
incidence of atherosclerosis and coronary heart disease according to a 
number of studies (Kromhout et al., 1995). The relationship between dietary 
fats and atherosclerosis has been extensively investigated, with strong and 
consistent associations emerging form a wide body of evidence accrued 
from animal experiments, as well as observational studies, clinical trials and 
metabolic studies conducted in diverse human population saturated fatty 
acids arise in total and low-density lipoprotein (LDL) cholesterol levels. The 
replacement of saturated and trans fatty acids by polyunsaturated vegetable 
oils lowered   coronary heart disease risk (Fransco et al., 2001). 
           It is becoming increasingly evident that immune mechanisms 
influence atherosclerosis; therefore the aim of this study was to investigate 
and evaluate the effect of increased high levels of dietary cholesterol 
(hypercholesterolemia) and saturated fat on development of atherosclerotic 
lesions that result from a cascade of cellular and molecular responses. Since 
the relation between dietary fat and atherosclerosis is a contentious field of 
study, and there is no research indicating whether or not there is direct 
association between dietary cholesterol and dietary saturated fats with 
atherosclerosis, therefore, comprising  rats fed high cholesterol versus 
saturated fats diets, by measuring  atherogenic parameters which involve the 
blood total and differential count of leukocyte, serum proteins, 
immunoglobulin concentration and histopathological change in same 
experiment, will add to the knowledge in this  area by high lighting the more 
influenced group and which parameters. 
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CHAPTER ONE         
LITERATURE REVUEW 
1.1 Lipids and dyslipidemia 
          Lipids are important dietary constituent not only because of their high 
energy value also because of fat soluble vitamins and essential fatty acid 
contained in the fat of natural foods (Paterson, 2000). Lipids play main roles 
in biological systems. Like carbohydrates, they are essential component of 
membranes, they function as hormones, and they can serve as padding and 
thermal insulator.  Lipids are complex and heterogeneous groups of 
compounds that they defy rational classification.  However despite their 
difference in structure, they share the property of being insoluble in water. 
Indeed they are so insoluble that they require special water-soluble lipid-
protein complex (lipoprotein), for transport in the blood stream (Murray, 
2000). 
            Increasing lipid levels in a fully dilated normal coronary bed causes 
no change in large or small vessel dimensions. Instead, the increase in blood 
viscosity causes capillary resistance to rise, which attenuates hyperemic 
coronary blood flow (CBF). Therefore, the abnormal CBF reserve 
associated with hyperlipidemia is due to increase blood viscosity and not 
abnormal vascular function (Ross, 1993). Lipoproteins are means by which 
mostly insoluble substances are kept in solution. These complexes form 
large to very large molecules. Since changes in lipid components in disease 
result in changes in the types of lipoprotein present in the plasma and 
classification of these diseases are based on alterations in the lipoprotein 
(Ganong, 1997). Lipoproteins are complexes of lipids and proteins held 
together by non-covalent bonds. The core is of insoluble (non-polar) 
cholesterol esters and triglycerides, surrounded by proteins (known as 
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apolipoproteins), phospholipids and free cholesterol with their water soluble 
(polar) groups facing outwards. The most important are the lipoproteins of 
the plasma, which function as major transporters of lipids. Lipoproteins are 
classified based on their density to five fractions including high density 
lipoproteins (HDL), low density lipoproteins (LDL), intermediate density 
lipoproteins (IDL), very low density lipoproteins (VLDL) and 
chylomicrones (Davidson and Sittman, 1994). Chylomicrones are derived 
from the intestinal absorption of triglycerides. The VLDL is synthesized in 
the liver for exportation of triglycerides to the extra-hepatic tissues; LDL is 
the final stage in the catabolism of VLDL; IDL is a transient lipoprotein 
formed during the conversion of VLDL to LDL, it contains both 
triglycerides and cholesterol, IDL is usually undetectable in normal plasma 
(Zilva et al., 1994). HDL is involved in VLDL and chylomicrones 
metabolism and also in the transport of cholesterol to the liver (Murry et al., 
2003).  
             Dyslipidaemia, which can range from hypercholesterolemia to 
hyper lipoproteinemia, is one of the many modifiable risk factors for 
coronary artery disease (CAD), stroke and peripheral vascular disease 
(Chong and Bachenheimer, 2000). Atherosclerosis is a disease of the intima 
of large and medium-sized arteries. Prominent among resultant intimal 
changes is the focal accumulation of lipid, particularly cholesterol and 
cholesteryl esters, in fibro fatty plaques known as atheroma (WHO, 1958). 
The atheroma narrows the arterial lumen, damage the underlying media and 
frequently become ulcerated and/or calcified, thus further narrowing the 
arterial lumen. In humans, this disease most commonly affects the 
abdominal aorta, coronary, iliac, femoral and cerebral arteries (Wissler, 
1980). A vast number of hypotheses to elucidate pathogenesis of 
atherosclerosis have been published. Some of them were lipid hypothesis, 
thrombogenic hypothesis and endothelial cell injury hypothesis. 
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Controversy still remains as to the relevance of blood haematology and 
biochemistry during the development of atherosclerosis; some investigators 
have suggested that some blood parameters of rabbits fed high cholesterol 
diet increased in oppose to control rabbits, while others suggested the 
opposite. A great numbers of studies have revealed that chronically elevated 
lipids levels and cholesterol levels are associated with an increased 
incidence of atherosclerosis (Abdelhalim et al., 1994). 
               Evidence from experimental, clinical and epidemiological studies 
have been suggested that several hemostatic and hemorheological factors 
such as fibrinogen levels, plasma viscosity, hematocrit, RBC aggregation 
and WBC counts might not only play an important role in the evolution of 
acute thrombotic events, but may also take part in the pathophysiology of 
atherosclerosis (Tamura et al., 2007; Loimaala et al., 2006; Wolfgang and 
Edzard, 1992). High triglyceride TC and LDLC have been correlated with 
the increased risk of atherosclerosis (Martine, 1986). Triglyceride-rich 
lipoproteins of both intestinal and liver origin were considered atherogenic 
factor (Zilversmit, 1995; Philips et al., 1993). Activation of leukocytes is 
obligatory for inflammation and atherogenesis by adhering to the 
endothelium via specific ligands. There is a triglyceride (TG)-specific 
increase of neutrophil counts and increased activation of monocytes and 
adhesive capacity of these cells contributing to the inflammatory component 
of atherosclerosis (Van Oostrom et al. 2004). It has been hypothesized that 
higher neutrophil percentage are associated with an increased incidence of 
major adverse cardiovascular events in patients with clinically advanced 
atherosclerosis. In patients with peripheral artery disease, only neutrophils 
counts, but not eosinophiles, basophiles, monocytes, lymphocytes, or total 
WBC count indicated a substantially increased risk for major adverse 
cardiovascular events (Markus et al., 2005). Although the underlying 
mechanisms of atherosclerosis and intimai hyperplasia remain unclear, the 
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basal adherence of monocytes only was significantly elevated in 
atherosclerosis, resulting in increased adherence to endothelial cells 
(Dovgan et al., 1994). Fibrinogen concentration has been identified as 
independent atherosclerotic risk factors during the development of 
atherosclerotic plaques and thrombi (Ernst and Resch, 1993; Danesh et al., 
1998). Elevated plasma fibrinogen level has known to progress 
atherosclerosis and to be one of the risk factors for the occurrence of 
cardiovascular diseases (Yoshiyasue, 1996). Dietary cholesterol increased 
blood total leucocytes count, serum and liver total cholesterol 
concentrations, low-density lipoprotein concentration and induction of 
atherosclerotic plaques in the aorta and coronary arteries (Meijer et al., 
1996). 
            It has been shown convincingly that fatty liver is associated with, 
atherosclerosis, and the metabolic syndrome. Furthermore, fatty liver 
predicts future cardiovascular events. It is thought that a pro-atherogenic 
serum lipid profile, which is commonly observed in subjects with fatty liver, 
is in part responsible for these relationships. This profile consists of low 
HDL cholesterol and high triglyceride levels, small, dense LDL particles, 
and high apolipoprotein B100 levels. An increased rate of hepatic 
triglyceride synthesis and VLDL particle production, which secondarily 
results in low HDL cholesterol and increased LDL particle density, is 
considered to be causative for this type of dyslipidemia. Furthermore, a 
decrease in lipoprotein lipase activity may also be involved (Norbert, 2007).  
1.1.1 Saturated fats 
       Lipid that occurs naturally in living matter contains varying proportions 
of saturated and unsaturated fats. Foods that contain a high proportion of 
saturated fat are suet, egg, tallow, lard, dairy products, meat, and some 
prepared foods.Saturated fatty acids have no double bonds between the 
carbon atoms of the fatty acid chain; hence, they are fully saturated with 
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hydrogen atoms. Lauric and myristic acids are most commonly found in 
‘tropical’ oils. Diets high in saturated fat are correlated with an increased 
incidence of atherosclerosis and coronary heart disease according to a 
number of studies. Epidemiological studies have found that those whose 
diets are high in saturated fatty acids, including lauric, myristic, palmitic, 
and stearic acid, had a higher prevalence of coronary heart disease. 
Additionally, controlled experimental studies have found that people 
consuming high saturated fat diets experience negative cholesterol profile 
changes (Francisco et al., 2001). The World Health Organization has 
determined that there is ‘convincing’ evidence that myristic and palmitic 
acid intake increases the probability, ‘possible’ risk from lauric acid, and no 
increased risk at all from stearic acid consumption (Francisco, 2001).  
  Experiments in which subjects were randomly assigned to either a control 
or Mediterranean diet (which replaces saturated fat with mono and 
polyunsaturated fat) showed that subjects assigned to a Mediterranean diet 
exhibited a significantly decreased likelihood of suffering a second heart 
attack, cardiac death, heart failure or stroke (De Lorgeril et al., 1999). Some 
prospective studies show that replacing saturated fat with unsaturated fat is 
more effective in lowering CHD risk than reducing total fat consumption 
(Carla et al., 2007). 
         It is reported that acyl- CoA:cholesterol acyltransferase (ACAT2) gene 
deletion prevents hypercholesterolemia and atherosclerosis induced by diets 
containing 10% saturated or monounsaturated fat in a murine(Beegorn et 
al., 2007). 
1.2 The cholesterol  
             Cholesterol is precursor of all other steroids in the body, e.g., 
corticosteroids, sex hormones, bile acids, and vitamin D. it is also an 
important amphipathic lipid, which allows it to play a structural role in 
membranes and in the outer layer of lipoproteins. Most of the cholesterol is 
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synthesized by the body and some has dietary origin (Robert, 2006). The 
effects of feeding cholesterol examined in the rat jejunal mucosa on 
cholesterol absorption, biosynthesis, esterification, and LDL receptor 
function feeding2% cholesterol for 1 week increased the amounts of 
absorbed cholesterol 27-fold, even though the percent absorption 
significantly decreased. Cholesterol feeding down regulated both total 
jejunal HMG-CoA reductase activity and receptor-mediated LDL binding 
(Peter, 1998). Cholesterol-fed normal Wistar albino rats show functional 
changes in vascular responsiveness even with a relatively small elevation of 
plasma cholesterol levels (Dietschy, 1997). 
             Cholesterol from the liver and intestine is transported in plasma. 
About 75% esterifies with fatty acids and the rest unesterified. It is taken up 
from plasma by different tissues. Its main route of metabolism is to bile 
acids, which are secreted into bile as conjugated with glycine or taurine. 
Unesterified cholesterol is also secreted into bile, and both undergo an 
entero-hepatic-circulation with some loss of cholesterol and bile acids occur 
daily in the faeces. Unlike that of triglycerides, plasma concentration of 
cholesterol does not rise after a fatty meal (Johnson et al., 1991). 
        Recent observations liver plays a key role in the inflammatory response 
evoked by dietary constituents. For example, liver derived inflammation 
markers such as C-reactive protein (CRP) and serum amyloid A (SAA) 
increase rapidly (within days) after consumption of an excess amount of 
dietary lipids and thus by far precede the onset of early aortic lesion 
formation. These findings suggest that nutritional cholesterol itself may 
contribute to the evolution of the inflammatory component of atherogenesis. 
They postulated that proatherogenic inflammatory factors originate at least 
partly from the liver. They also hypothesized that these factors come into 
play at high dietary cholesterol doses because of the exponential rather than 
linear nature of the relationship between cholesterol intake and 
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atherosclerotic lesion size. In this study they sought evidence for the 
hypothesis that inflammation and hypercholesterolemia are not separate 
factors, but closely related features of the same trigger of dietary 
cholesterol. In particular, using a variety of newly developed functional 
bioinformatics tools, they addressed the question of how the liver responds 
to increasing dietary cholesterol loads at the gene transcription level and 
analyzed how hepatic cholesterol metabolism is linked to the hepatic 
inflammatory response, including underlying regulatory mechanisms. 
Notably, all analyses were performed at a very early stage of the atherogenic 
process (that is, after 10 weeks of cholesterol feeding) to limit potential 
feedback reactions from the vessel wall (Robert, 1993). 
            Dietary cholesterol is not only a lipid risk factor but also a trigger of 
hepatic inflammation and, as such, also involved in the evolution of the 
inflammatory arm of atherosclerotic disease. A certain degree of genetic 
resilience and elasticity allows the liver to cope with moderate cholesterol 
stress, but high loads of cholesterol result in an inflammatory pro-
atherogenic response (involving specific pathways and transcriptional 
regulators), which enhances early lesion formation. The findings that 
cholesterol and inflammation are closely linked via specific transcriptional 
master regulators might lead to new strategies for future therapeutic 
intervention (Robert, 1993). 
            Immune systems of men in a low cholesterol group were found to be 
significantly less effective than those of high cholesterol group. This finding 
was not surprising as several studies have shown that cholesterol is 
necessary for the proper functioning of blood cells macrophages and 
lymphocytes that form part of our immune systems. For this reason low 
blood cholesterol undoubtedly adversely affects our bodies' ability to fight 
infection. This could well be another reason why infectious diseases are 
becoming more prevalent in our society (Paterson et al., 2000). 
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           Low cholesterol is also linked to increased susceptibility to infection, 
including development of postoperative infection (Lande et al., 2001) and it 
predicts death and adverse outcomes in hospitalized patients (Cabin et al., 
1999) .While some of this could be due to illness causing lower cholesterol, 
it may also be that low cholesterol contributes to illness; indeed, animal 
studies suggest lipoproteins may serve to protect against bacterial infection-
induced death. It has been suggested in cases of critical surgical illness that 
a low cholesterol level is more likely to lead to the development of organ 
failure and death. A study of patients undergoing surgery for gastrointestinal 
diseases at the Universita di L'Aquila in Italy, found that 
hypocholesterolemia low blood cholesterol seems to represent a significant 
predictive factor of morbidity and mortality in critically ill patients (Reed et 
al., 1993). 
1.3 The effect of hyperlipidemia on some biochemical measures 
1.3.1 Serum total protein 
            Plasma protein comprises the major part of solids in plasma. It 
includes simple proteins, conjugated protein and lipoproteins. Plasma 
proteins mostly synthesized in hepatocytes, except for immunoglobulins, 
which are synthesized in the lymophoreticular system (McDonald, 1985). 
          The concentration of plasma proteins may be altered in diseases that 
affect protein metabolism, and in case of dehydration or over hydration. 
Most diseases that alter plasma affect the syntheses of proteins or the rate of 
catabolism and the rate of excretion (Whitby, 1984). 
           Strong additional support was provided for the existence of a 
significant positive relation between the activity of cholesterol ester transfer 
protein (CETP) and concentrations of (LDL), hypercholesterolemia and 
hyperlipidemia. At the same time, high CETP levels may help to confer the 
low HDL cholesterol levels found in hypercholesterolemia patients. The 
current observation that CETP activities are positively correlated with 
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cholesterol concentrations in apo B–containing lipoproteins in the plasma 
and inversely correlated with HDL cholesterol levels lends support to the 
concept that CETP activities do influence the concentrations of lipoprotein 
cholesterol (Federico, 1995). 
          C - reactive protein (CRP) levels were significantly elevated in both 
cholesterol-fed and hyperlipidemia; CRP levels were clearly correlated with 
aortic atherosclerotic lesion size. Immunohistochemical revealed that     
CRP-immunoreactive proteins were found at all stages of atherosclerosis 
from the early to advanced lesions. CRP was present extracellular and co-
localized with apolipoprotein B but was rarely associated with the 
cytoplasm of macrophages and foam cells. Real-time reverse transcriptase-
polymerase chain reaction analysis revealed that CRP mRNA in 
atherosclerotic lesions was barely detectable, and isolated macrophages did 
not express CRP mRNA, suggesting that CRP proteins found in the lesions 
were essentially derived from the circulation rather than synthesized de 
novo by vascular cells. These results suggest that there is a link between 
plasma CRP and the degree of atherosclerosis and that inhibition of plasma 
CRP may represent a therapeutic modality for the treatment of 
cardiovascular disease (Paterson, 2005). 
1.3.2 Serum albumin: 
             Albumin is present in the highest concentration of plasma proteins, 
although it has the lower molecular mass, when compared to other proteins. 
Albumin acts as non-specific vehicle for large number of indigenous 
substances that include fatty acids, calcium, bilirubin, thyroxin and urates, 
in addition to transport of many drugs. Albumin is synthesized in 
hepatocytes and its synthesis may be reduced in hereditary defects, liver 
diseases, malnutrition and malabsorptive disease (Whitby, 1984). 
          Albumin is synthesized in the liver, and circulating cytokines 
influence its production. Interleukin (IL)-6, a cytokine that has both 
11
 
 
proinflammatory and anti-inflammatory properties, is released in response 
to IL-1 and tumor necrosis factor-α. This release leads to an acute-phase 
reaction in which the synthesis of albumin is depressed and the synthesis of 
acute reactant proteins (Creactive protein, amyloid A, and α-1 acid 
glycoprotein) is increased (Heinrich, 1990). Epidemiological studies have 
suggested that lower concentrations of serum albumin are associated with an 
increased risk of cardiovascular disease (CVD); previous epidemiological 
studies have suggested that lower levels of serum albumin are associated 
with an increased risk of CVD due to hyper cholesterlemia and 
hyperlipidemia and mortality. It is not known whether low serum albumin is 
associated with early signs of atherosclerosis (Weijenberg, 1997) In 
contrast, some investigators have reported an inverse association between 
serum albumin and carotid atherosclerosis among subjects with renal 
disease (Stenvinkel, 1999). The association between serum albumin and the 
risk of CVD has been inconsistent, due to it has been suggested that low 
albumin might not be an independent risk factor of CVD and mortality but 
rather a reflection of cytokine activation and ongoing IL-6 –mediated 
subclinical inflammation. Atherosclerosis can be viewed as an inflammatory 
disease. It is thus possible that low albumin merely reflects the 
inflammatory process and is not causally related to atherosclerosis, CVD, 
and mortality. On the other hand; several studies have reported an 
association between serum albumin and mortality. If low albumin is only an 
indication of an existing inflammation, one would not expect to observe an 
association between low albumin and mortality in the absence of 
inflammation (Ross, 1999). 
1.3.3 Serum total globulins 
           Globulins are globular proteins that precipitate in water and required 
salt to maintain their solubility. In contrast to albumin, one of the major 
features of globulins is that they are not a single discrete species of protein. 
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Globulin, a larger protein than albumin, is important for its immunologic 
responses, especially its gamma portion (IgA, IgG, IgM, and IgE). 
Globulins have many diverse functions such as, the carrier of some 
hormones, lipids, metals, and antibodies. When chronic infections, liver 
disease, rheumatoid arthritis, myelomas, and lupus are present, elevated 
levels are seen. You may find lower levels in immune compromised 
patients, poor dietary habits, malabsorption and liver or kidney disease. 
Immunoglobulins are group of glycoproteins, present in the serum and 
tissue fluid of mammals, produced by plasma cell. This developed from 
precursor B-lymphocytes (Roitt, 1989).       
1.4 The effect of hyperlipidemia on the leukocytes                                                           
1.4.1 Leukocytes 
              Leukocytes and certain phagocytes cells are all delivered from bone 
marrow stem cells. And their function is to engulf particles, internalized 
them and destroys them (Roitt, et al 1989). The process of phagocytosis can 
be divided into four stages, attachment of the particulate matter to the cell 
surface, engulfment of such particle; intracellular killing of the 
microorganism and digestion of the digested matter (Cohn, 1968 Hirsch, 
1965).Wondering cells are polymorph nuclear cells, which adhere to the 
particle, by surface phogocyteisis. After opsonization, they kill the ingested 
microorganism by the enzymatic contact of the lysosmes (Tizard, 1977). 
Granulocytes remain in the peripheral blood for only short time, before they 
migrate through the vessel wall into the tissues, where they survive for only 
few days. Monocytes reside in the circulation for two to three days and then 
emigrate into the tissues to become tissue macrophages which are long 
living cells.  The fixed cells (tissue macrophages) are distinguished free 
macrophages which are present in connective tissues and serous cavities and 
fixed macrophages of organs e.g. liver (kuffer cells). The spleen and lymph 
nodes; both types of phagocyte cells contain acid hydrolyses e.g. acid 
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phosphates ribonuclease, deoxy ribonuclease, glucourinidase, and cathepsin, 
capable of destroying the ingested materials (Chon, 1968). They are motile 
and migrate towards a concentration gradient of a chemoattaractent released 
in the vicinity of the microorganism through a process called chemotaxis. 
Macrophages and polymorph neutrophils possess receptors for antibody and 
or other component of the complement system. Microorganism opsonized 
by antibodies or by complement bind to the surface receptors of theses 
phagocytic cells, resulting into subsequent phagocytosis and killed by these 
cells (Chew, 1987). There is independent association of neutrophil count 
with the angiographical characteristics of coronary atherosclerosis. Strongly 
suggests that granulocytosis may play a role in the development of coronary 
atherosclerosis. The intake of dietary fatty acids might have been sufficient 
to change lymphocyte fatty acid. Therefore, presumed alterations in fatty 
acid composition of lymphocyte membrane phospholipids might have 
resulted in decreased antibody production to the efficiency of the immune 
response relies not only on specific recognition of foreign antigens, but also 
on the amplification of lymphocyte proliferation. Unsaturated fatty acids 
can inhibit cell proliferation by an eicosanoid-independent action. 
Additionally, high concentrations of unsaturated fatty acids can cause 
apoptosis or necrosis through rapid loss of membrane integrity, lysosomal 
leakage, or cellular swelling. Therefore, changes in phospholipids fatty acid 
composition may alter the dynamics of membrane fluidity and plasma 
membrane characteristics that ultimately affect the immune system, which 
has been observed with macrophage function (De Pablo and De Cienfuegos, 
2000). This may be attributed to changes produced in the activity of proteins 
associated with membranes acting as receptors or ion channels. Therefore, 
binding of cytokines to their respective receptors on lymphocyte membranes 
may be altered. Leukocyte-derived microparticles (MP), identified by 
affinity for CD11a, are increased with subclinical atherosclerosis. 
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Circulating leukocyte-derived (MP) was related to metabolic syndrome, and 
presence of preclinical atherosclerosis. These relationships of leukocyte-
derived MP with atherosclerosis were independent of all risk markers, 
leukocyte count, and concomitant drugs. These data unveil new directions 
for atherosclerosis research (Gilles et al., 2006). 
1.5 Effect of hyperlipidemia on the immunity 
1.5.1 The immunity 
              Immunity is the sum of naturally occurring defense mechanisms that 
protect the body against environmental agents which are foreign to the 
body; these agents may be microorganisms or their products, food, 
chemicals or drugs. There are two types of immunity. 
• Non-specific or innate immunity.  
• Specific or acquired immunity. 
     Innate immunity is the process by which all animals resist the invasion of 
foreign or potentially harmful microorganism, by natural means without the 
production of protective antibodies. The natural means includes epithelial 
barriers, inflammation, compliment, acidic pH of the stomach and 
phagocytosis (Bryant, 1986). 
            Acquired immunity is more specialized and present only in 
vertebrates. Immunity is acquired by contact with invader and is specific to 
that invader initialy contact with the foreign agent (immunization). An 
exhibited specific reactivity against the foreign agents, by this the individual 
acquires immunity to resist subsequent attacks by the same agent. The 
compound to which the acquired immune response is induced is termed an 
antigen in a process known as vaccination (Benjamin et a., l 1996). 
           Acquired immunity can be cellular, which is mediated in part by 
lymphocyte products of high molecular weight (lymophokines). It is 
responsible for delayed allergic reactions and rejection of transplants of 
foreign tissue it constitutes the major defense against infections due to 
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viruses, fungi, and few bacteria such as the tubercle bacillus (Ganong, 
1997).  
           Hummoral immunity, which refers to the synthesis of free antibodies 
into the blood and other body fluids, these antibodies are capable of direct 
combination and neutralization of bacterial toxins. Acquired immunity 
against infectious of diseases may be countered by actual infection that 
causes the production of specific protective antibodies (active immunity). 
Or by artificial transmission of antibodies which offers temporary 
production of antibodies against invading organisms (passive immunity) 
(Bryant, 1986).  
1.5.2 Lipid and immune response 
            After prolonged feeding on an unphysiological diet, containing high 
level of cholesterol and saturated fat caused a chronic inflammatory state; it 
might have induced perturbation the interplay of immune cells and 
cytokines involved in atherogenesis (Peter, 1998). Many researchers have 
suggested that the blood lipids play a key role in the immune defense system 
(Gallin et al., 1996). There is also a growing understanding that an 
inflammatory response of the arterial intima to injury is a crucial step in the 
genesis of atherosclerosis, and that infection may be one type of such injury 
(Ross, 1986). These two concepts are difficult to harmonize with the low-
density-lipoprotein (LDL) receptor hypothesis, according to which high 
LDL cholesterol is the most important cause of atherosclerosis. However, 
the many observations that conflict with the LDL receptor hypothesis may 
be explained by the idea that high serum cholesterol and/or high LDL are 
protective against infection and atherosclerosis (Kromhout et al., 1995).  
           LDL, which may be modified by oxidation, or incorporation into 
immune complex’s, is major cause of injury to the endothelium and 
underlying smooth muscle. When LDL, particles become trapped in an 
artery, they can undergo progressive oxidation and be internalized by 
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macrophages by means of the scavenger receptors on the surfaces of these 
cells. The internalization leads to the formation of lipid peroxides and 
facilitates to accumulation of cholesterol esters, resulting in the formation of 
foam cells the degree to which LDL is modified can vary greatly. Once 
modified and taken up by macrophage, LDL activates the foam cells. 
Removal and sequestration of modified LDL are important parts of the 
initial, protective role of the macrophage in the inflammatory response and 
minimize the effects of modified LDL on endothelial and smooth-muscle 
cells. In addition to its ability to injure these cells, modified LDL is 
chemotactic for other monocytes and can up-regulate the expression of 
genes for macrophage colony-stimulating factor and monocyte chemotactic 
protein derived from endothelial cells. Thus, it may help expand the 
inflammatory response by simulating the replication of monocyte-derived 
macrophages and the entry of new monocytes to lesions (Ross, 1999). 
           It is becoming increasingly evident that immune mechanisms 
influence atherosclerosis. Atherosclerotic lesions consistently contain 
macrophages and T lymphocytes, two cell types that interact with each other 
to promote cell-mediated immune responses. In addition, antibody 
responses to modified lipids found in atheromas are characteristic of the 
disease. It has been proposed that T cells recognize peptides derived from 
oxidatively modified low-density lipoprotein (oxLDL), thereby promoting 
B-cell activation and production of anti-oxLDL antibodies (Paterson, 2000). 
            Substantial amount of evidence links infections to cardiovascular 
diseases (CVD). Epidemiological and mechanistic studies imply that 
infectious agents, such as Chlamydia pneumoniae, Helicobacter pylori, 
herpes viruses, and periodontal pathogens, enhance atherogenesis. Pathogen 
burden consisting of multiple microbial species increases the risk for CVD 
more than any single pathogen. The relationship between infections and 
CVD is, however, intricate, since a variety of common underlying factors 
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contribute to both conditions. For instance, the acute-phase response to 
infection is accompanied with a complex cascade leading to changes in 
concentrations of serum proteins and alterations in lipoprotein metabolism. 
Changes in lipid profiles during infection are related to the type, severity, 
and duration of the infection. Increased triglyceride and decreased high-
density lipoprotein (HDL) cholesterol concentrations are the most notable 
unfavorable changes in the plasma lipid profile during both chronic and 
acute infections. High triglyceride concentration is an independent risk 
factor for CVD in the general population. It has also been shown in 
numerous epidemiological studies that low HDL cholesterol concentration 
increases the risk for CVD. Even though acute-phase reactions influence 
metabolism in all lipoprotein classes, HDL is the first lipoprotein class to be 
affected by infection. The favorable, antiatherogenic potential of HDL is 
owing to its role in reverse cholesterol transport and in its ability to protect 
low density lipoprotein (LDL) from oxidation. Additionally, HDL 
participates in detoxification of bacterial lipopolysaccharide (LPS) in 
circulation, thereby, reducing provocation of proinflammatory reactions in 
infections caused by gram-negative bacteria (Tizard, 1977). 
1.6. Immunoglobulins 
            The immune system of the body consists of two major components; B 
lymphocytes and T lymphocytes. The B lymphocytes are mainly derived 
from bone marrow cells in higher animals and from the bursa of Fabricius in 
birds. The T lymphocytes are of thymic origin. The B cells are responsible 
for the synthesis of circulating, humoral antibodies, also known as 
immunogloblins. The T cells are involved in a variety of important cell-
mediated immunologic processes. Specialized cells of B cell linage 
synthesize and secrete immunoglobulins to the plasma. There are five 
immunoglobulin classes: IgG, IgA, IgM, IgD and IgE according to the type 
of heavy chain immunoglobulin’s structure (Robert, 1993). Circulating 
  18
 
 
antibodies against (oxLDL) are present in several inflammatory and 
autoimmune conditions. Such antibodies are also present in patients with 
atherosclerosis, although the pathogenic significance of the antibodies is 
still not known, antibodies characterized with regard to isotype, subclass, 
affinity and effect on macrophage uptake of oxLDL. Antibodies of IgG and 
IgM isotype were most common and found both in patients with 
atherosclerosis and in normal individuals. The subclass of IgG antibodies 
were heterogeneous with regard to affinity, whereas only one population of 
high-affinity antibodies was found in the IgM antibody population, the high-
affinity populations had an average equilibrium constant for IgG and IgM 
antibodies. Incubation of oxLDL with purified IgG and IgM from sera with 
high amounts of antibodies enhanced the uptake of oxLDL in the monocyte-
like cell line. Antibody preparations from sera containing no anti-oxLDL 
antibodies and from sera with antibodies against LDL had less effect on this 
uptake. The increased uptake was competitively decreased by adding 
unlabelled oxLDL. This study shows that antibodies against oxLDL are 
mainly IgG2, IgG3 and IgM. Both IgG and IgM antibodies have a high 
affinity for the antigen and increase the uptake of oxLDL in a monocyte-like 
cell line (Fridman et al., 1995). Fatty acids have important regulatory roles 
in cellular function and may potentially alter signal transduction (Clew et 
al., 2002). For example, saturated fatty acids, primarily myristic and 
palmitic acid, are covalently attached to membrane proteins and are believed 
to be involved with regulating intracellular signaling (Clew, 2002). 
Additionally, antibody production and secretion in response to antigen 
stimulation can be modulated by fatty acids. For example, inclusion of 
linoleic acid in the diets of mice impaired production of antibodies, 
including IgG after antigenic challenge (Paterson et al., 2000). 
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1.7 The Immune system and the atherosclerosis 
           Atherosclerosis develops from low-density lipoprotein molecules 
(LDL) becoming oxidized by free radicals, particularly oxygen free radicals. 
Blood in arteries contains plenty of oxygen and is where atherosclerosis 
develops. Blood in veins contains little oxygen where atherosclerosis rarely 
develops. When oxidized LDL comes in contact with an artery wall, a series 
of reactions occurs to repair the damage to the artery wall caused by 
oxidized LDL. The LDL molecule is globular shaped with a hollow core for 
carrying cholesterol throughout the body for making brain tissue, vitamin D, 
etc. Cholesterol does not dissolve in water. Blood is 70% water. The only 
way cholesterol can move in the bloodstream is to be carried by LDL. The 
body's immune system responds to the damage to the artery wall caused by 
oxidized LDL by sending specialized white blood cells (macrophages and 
T-lymphocytes) to absorb the oxidized-LDL. Unfortunately, these white 
blood cells are not able to process the oxidized-LDL, and ultimately grow 
then rupture, depositing a greater amount of oxidized cholesterol into the 
artery wall. This triggers more white blood cells, continuing the cycle. 
Eventually, the artery becomes inflamed. The cholesterol plaque causes the 
muscle cells to enlarge and form a hard cover over the affected area. This 
hard cover is what causes a narrowing of the artery,   reduces the blood flow 
and increases blood pressure (Maton et al., 1993).  The oxLDL behaves as a 
potent inflammatory agent. In vivo administration of oxidized LDL to mice 
causes’ rapid induction of circulating macrophage colony stimulating 
factors (M-CSF) and upregulation of genes encoding as well as other 
inflammatory proteins in various tissues oxLDL stimulates the expression of 
adhesion molecules. On endothelial cell (EC); oxLDL has chemoattractant 
activity on monocytes, promotes their differentiation into macrophages, but 
inhibits their mobility, binding of oxLDL to CD36 triggers the release of 
proinflammatory cytokines in macrophages. In addition, incubating human 
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blood mononuclear cells with oxLDL results in T-lymphocyte activation, as 
assessed by increased expression of IL-2 receptors on T lymphocytes, 
Oxidation of LDL generates many “neo-self determinants” that induce an 
active immune response and may challenge the regulatory pathways 
responsible for immune homeostasis. Both humoral and cellular immune 
responses can profoundly affect atherosclerotic development and 
progression. The amount of lipid retained in macrophages depends on 
unregulated uptake of oxidized lipoproteins by scavenger receptors, as first 
identified counterbalanced by degradation and efflux. Altogether these 
findings point to a role of oxLDL as a very early trigger of vascular 
inflammation. LDL accumulation and modification in the subendothelium 
trigger monocyte and lymphocyte recruitment. Thereafter, activated 
macrophages and lymphocytes secrete abundant amounts of cytokines that 
in turn can activate EC, SMC, and macrophages/lymphocytes to foster 
cytokine production, leading to a self-perpetuating inflammatory process 
that becomes less dependent on the presence of oxLDL. This might explain 
why oxLDL, triggering the early atherosclerotic events, are less critical in 
upholding the inflammatory environment. They found T cell, which mediate 
adaptive immunity, are an early and important component of lesions, and 
macro-phages, which play a key role in both lesion development and in 
mediating plaque disruption, serves to bridge innate and adaptive immune 
processes. Immune-globulins are abundant in the plaque, in part complexes 
to lesion epitopes, such as oxidation-specific epitopes of oxidized LDL 
(OxLDL). However, B cells themselves are noticeable for their absence, 
though they have been reported in the adventitia surrounding diseased 
vessels. Specific humoral, as well as cellular immunity has been 
demonstrated to a number of antigens in the atherosclerotic lesion, including 
viral and bacterial antigens, heat-shock proteins, modified arterial wall 
elements, and especially OxLDL. Indeed, autoantibodies to a variety of 
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oxidation-specific epitopes of OxLDL, such as that modeled by 
malondialdehyde-modified LDL (MDA- LDL) have generally been shown 
to correlate with the extent of lesion formation. The studies teach us that if 
the atherogenic pressure is exceedingly high, immune function is not 
obligatory for the initiation or progression of lesion formation, but under 
conditions of more moderate atherogenic pressure, the immune response 
play proatherogenic role. Indeed, most studies of immune modulation to 
date have indicated a proatherogenic influence of the immune system on 
atherogenesis. For example, neutralizing CD40L interactions, either 
genetically or by infusion of blocking antibodies, reduces lesion formation, 
as does blocking of the activity of the Th1 cytokine INF-γ. This subject has 
been covered in depth in several recent reviews. During evolution, an 
increasing number of genes have been devoted to the expansion of what can 
be collectively called immune function. Surely, the genetic selection of such 
a complex system must have some important survival advantage. 
Atherosclerosis is only manifested beyond the reproductive period. And 
thus is not likely to exert any evolutionary pressure itself. However, it is 
now apparent that there are generalized responses to inflammatory 
components of the atherogenic process that are shared with those seen in 
infectious and acute and chronic diseases. It is likely that such responses 
exert selective positive pressure on immune components that could also 
exercise protective mechanisms with regard to atherogenesis. For example, 
hyperimmunization of hypercholesterolemia murine models with OxLDL 
epitopes, so as to achieve very high plasma titers of antibodies to OxLDL, 
ameliorates atherogesis, as does the intravenous administration of 
polyspecific IgG isolated from pooled donors. Apo E, mice develop very 
high titers of IgM autoantibody to a variety of oxidation-specific 
neoepitopes on OxLDL. Furthermore, it has recently been demonstrated that 
IgM monoclonal autoantibodies to OxLDL, cloned from the spleens of such 
  22
 
 
cholesterol fed Apo E mice, specifically bind to oxidized phospholipids 
epitopes and block the uptake of oxLDL uptake serves an anti-atherogenic 
fuction, as genetic deletion of scavenger receptors protects against 
atherogenesis in some genetic backgrounds. These antibodies also build to 
apoptotic cells, which display similar oxidized phospholipid epitopes. 
Interestingly, these antibodies, which are secreted by the spleen, have been 
shown to be identical to the T 15 clonospecific anti-phosphorylcholine (anti-
PC) antibodies, which arise without prior immunization and do not require 
germline recombination to achieve specificity for their target eptiopes. 
These so-called ‘natural’ antibodies confer optimal protection to mice 
against lethal infection with encapsulated organisms, such as Streptococcus 
pneumonia. Because these germline antibodies are found by day 7 in mice 
maintained in germ-free environments, it has been postulated that they are 
actually positively selected for their ability to clear oxidized membranes 
found on apoptotic cells. Subsequent exposure to microbial PC serves to 
exert further positive selection pressure. These antibodies are greatly 
expanded in the cholesterol-fed Apo E mice, presumably because of the 
presence of excess OxLDL. Thus, while much evidence supports a 
pathogenic role for many immune mediated mechanisms, there is, not 
surprisingly, also precedent for the observation that some aspects of 
immunity serve to decrease the progression of atherosclerosis as well 
(Joseph, 2002). 
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CHAPTER TWO 
MATERIALS AND METHODS 
 
2.1 Experimental design 
      The experiment was carried out and designed to investigate and compare 
immunological measures in Wistar albino rat fed high cholesterol diet 
versus high saturated fats diet. 
2.1.1 Experimental animals 
        Thirty Wister albino rats of both sexes, weighting 85 – 125g, 14 -16 
weeks old obtained from Department of Preventive Medicine, Faculty of 
Veterinary Medicine, University of Khartoum were used in this study. The 
rats were housed identically in stainless cages in room air. All rats were kept 
for two weeks as an adaptation period, with free access to water, and fed a 
standard laboratory diet as basal diet which fulfilled rat’s requirement which 
were obtained from the National Center for Research, Khartoum. 
2.1.2 Rats diet program 
       The diet composition includes the following in each kg: 
Wheat flour           692g 
Meat powder         265g 
Sodium chloride        3g 
Oil                         140g  
      The rats were allotted three different groups, and fed as follows for three 
succeed months:   
Group A: (control) fed rats diet   
Group B: received rats diet and 20g cholesterol powder per Kg diet 
(Sharma, 1984). 
Group C: received 140g of cow tallow as supplement to basal rats diet. 
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2.1.3 The equipments 
       Heparinzed blood capillary tubes, centrifuge, pipettes, heparinzed 
containers, plain containers and colorimeter.                                                                          
2.1.4 Chemicals  
Cholesterol powder. 
2.1.5 Collection and preservation of samples 
      One and half ml blood samples were collected from the orbital plexus of 
rat by means of capillary glass tube according to the method of Khanna et 
al., (1993). Blood from each rat was collected separately and put in two 
containers, one containing EDTA for hematological tests and the other with 
heparin for biochemical analysis. Plasma was separated by centrifugation at 
5000r p m for 15 min, and then it was kept frozen -20˚C until analyzed. For 
the biochemical analysis serum was collected three time 4 weeks intervals. 
At the end of the experimental period, the rats were scared for collecting 
tissues for histopathology. 
2.1.6 Histopathological samples 
        The specimens of the heart and liver were collected immediately after 
slaughter and fixed in 10% formalin for histopathology. 
2.1.7 Hematological methods 
       Hematological estimations were done according to the method of lea 
and Febiger (1975). 
2.1.7.1 Determination of total leukocyte count 
            Principle 
       For the determination of total leukocyte count, two mentors of dilution 
were tried, the test tube method and the Thoma white cell diluting pipette 
method. Leukocytes count is facilitated by destruction of erythrocytes in the 
blood sample by means of acetic acid. 
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 Reagents 
        Leukocytes diluents’ was prepared by 1% acetic acid in distilled water. 
Turks’ fluid composed of glacial acetic acid 1ml, 1% aqueous gention violet 
1%ml. distilled water up to 100ml. 
Procedure  
     The blood sample was thoroughly mixed then 0.02ml was pipette and 
discharged in to a test tube contain 0.38ml of the leukocyte dilating fluid. 
The pipette was rinsed thoroughly with the diluting fluid to ensure removal 
of all traces of blood. The test tube was covered with a rubber bung and 
mixed thoroughly by slow inversion so that a dilution of 1:20 was obtained.  
      The improved Neubauer haemecytometer and the cover-slip were 
cleaned with lens tissue and the coverslip was pressed on the surface of the 
haemecytometer. The diluted blood was remixed, then the capillary tube 
was used to fill the counting chamber and the cells were allowed to settle.  
      Under low power, using ×10 objective of the bright field microscope 
(KYOWA), the number of white blood cells was counted in each of the 4 
large corner squares. The rule for including and excluding cells toughing the 
lines was the same of erythrocyte count as fallow in order to avoid 
duplication in counting cells, cells that touch the top and the left center lines 
were counted , and the cells touching the bottom and right center lines were 
not counted.  
     The calculation was mode by multiplying the number of cells (N) 
counted by both dilution factor and volume factor  
     Each large corner square has an average area of 1mm and a depth of 
0.1mm, giving a volume 0.1µ. Since 4 large squares were used for counting 
the total volume was 0.4µ. Because the standard volume used in cell counts 
is 1µ, this should be multiplied by 2.5.  The dilution factor is 20, then as the 
4 squares have been counted, the total count was obtained as follows: 
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Total leukocyte count (X 10 /u) = N X (1/0.4) X 20 
                                = N X 2.5 X 20 
 = N X 50 
2.1.7.2 Differential leukocyte count 
a. Preparation of blood smears 
       The blood smear was prepared immediately after the collection of the 
blood sample. The slides were dipped in 95% alcohol and wiped with a dry 
lintless cloth. After mixing the blood sample by gentle agitation, a small 
drop of blood was placed near one end of the side (about ½ inch from the 
end), using a capillary tube or applicator stick. Then the slide was kept on a 
sold flat surface. A second spreader slide with a perfectly smooth edge was 
placed against the surface of the first slide at an approximate angle of 30 
degree. The spreader slide was drawn into the blood and when the blood 
was spread along two-third of the width by capillary action, the spreader 
slide was pushed forward with steady even motion; the blood followed the 
motion making a thin film.  
b. Fixation 
      The blood smear was dried by waving in the air or by using a fan. The 
smear was fixed by dipping in absolute methyl alcohol for 5 min.  
c. Staining 
      Gemsa powder (3-8 g) was transferred to a dry drawn bottle of 500ml 
capacity which contains a few glass beads. 250ml of methanol was added to 
the stain and mixed well. Then 250ml of glycerol were added to the stain 
and mixed well. The bottle of the stain was kept at room temperature and 
mixed well at intervals. The stain was stable for several months.  
     For use, a small amount of stain was filtered into a dry stain dispensing 
container. The blood film was flooded by dilute Gemsa stain (1:9) in 
coupling Jar for 20 minutes and rinsed well with distilled water and allowed 
to dry.  
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d. Performance of differential count 
      The blood film was examined under the microscope using an oil 
immersion lens (x 100) magnification.  
       The differential leukocyte count was doing by counting and classifying 
100 leukocytes. To give a representative sampling of all portion of the 
smear, examination of the smear was doing by battlement method. The 
result was expressed as percentage of neutrophiles. Lymphocyte, 
monocytes, eosinophiles and basophiles.   
2.1.8 Biochemical method 
2.1.8.1 Determination of serum total protein 
       Serum total protein concentration was determined calorimetrically 
according to the method described by Wootton and Freeman (1982), using 
Biuret reagent.  
 Principle  
      Copper in alkaline solution, reacts with the peptide bonds that links 
amino acids in protein producing a violet color. The intensity of the color is 
proportional to the concentration of protein present.  
 Reagents  
• Biuret reagent was prepared by weighing 9g Sodium potassium tartarate 
were dissolved in 500 ml of 0.2N.NaOH, and then 3g cupric sulfate was 
added.  
• Protein stock standard was prepared by dissolving 1g of crystalline BSA 
.and made up to 100 ml with distilled water (DW), few drops of 
chloroform were added as preservative. 
• Working standard was prepared by diluting 10 ml of stock standard to 
100 ml DW. To give concentration of 0.1 g/100.  
Procedure  
      Three test tubes labeled test, blank, and standard were prepared. To all 
tubes 5ml of pure reagent was added to the test 02 ml of serum, 2.8 ml DW 
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were added. To the standard 3 ml of working standard was added to the 
blank 3 ml of DW were added.  
        All tubes were mixed and incubated at 37˚C in water bath for 10 
minutes. The optical densities were read at 540 nm against blank. The 
concentration of protein was calculated as follows:  
  
2.1.8.2 Determination of serum albumin  
       Serum albumin was determined by the method of Bartholomew and 
Delaney (1966) using Bromocrysol green (BCG). 
Principle  
      Bromocrysol green (BCG) solution, a yellowish indicator, and reacts 
with serum albumin producing a blue green color, the color intensity was 
proportional to the concentration of protein presented.  
Reagents  
Molar solution of sodium citrates was prepared by dissolving 29.4 g 
trisoduim citrate in DW.and completed to 100 ml.  
Citric acid (Molar solution) was prepared by dissolving 21 g Citric acid in 
100 ml DW.  
Bromocrysol green (BCG, 01M) was prepared by dissolving 0.698 g BCG 
in 10 ml 0.1N NaOH, then completed to 100ml with DW  
Albumin standard was prepared by dissolving 4 g of BSA in 100 ml DW 
and kept at -20˚C. 
Working BCG solution was prepared by mixing 800 ml DW.6.0 ml 0.1M 
BCG, 17.3 ml trisodium citrate and 23 ml citric acid, then completed to one 
liter with DW at pH of 3.8, kept in brown bottle at 4˚C. 
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Procedure  
      Four-ml BCG solution wee pipette in to three test tubes, labeled test, 
blank, and standard. 0.2 ml of serum was added to the test, and standard to 
the blank 0.2 ml DW was added.  
        The tubes were mixed and the optical densities were read against blank 
at the wavelength of 630 nm. Serum albumin concentration was then 
calculated according to the following equation:  
  
 2.1.8.3 Determination of serum total globulins  
       Serum globulin was estimated according to Wunderlay and Wuhtmann 
(1960) by subtracting albumin from serum total proteins. 
2.1.9. ELISA for the Quantitative Determination of Anti-oxLDL IgG          
and IgM antibodies 
      Autoantibodies against oxLDL are used as markers of atherosclerosis, 
vascular diseases, and myocardial infarction. The IgG and IgM isotypes 
have the greatest clinical significance. Elevated anti-oxLDL antibody 
concentrations are found in case of atherosclerosis, myocardial infarction, 
hypertension, diabetes, renal failure dialysis, endometriosis and cigarettes 
smoking. In contrast to other methods, the innovative and patent pending 
IMTEC- ELISA exposes each serum sample to both oxLDL and native LDL 
in one microtiter well. The uncomplicated analytical procedure permits the 
synchronous determination of IgG and IgM antibodies (Conrad, 2002). 
Principle 
      The test is based on the simultaneous incubation (patent pending ) of 
serum samples with both oxLDL (immobilized on microtiter strips ) the 
native LDL (immobilized on pin of the TSP- plate)subsequent binding of 
anti-oxLDL-antibodies from patient serum to microtiter plate, is detected 
with an peroxidase-labelled secondary antibody that is directed against IgG 
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and IgM. After addition of substrate solution, a color appears which 
intensity is proportional to the concentration and/or the avidity of the 
detected antibodies.  Following the addition of stop solution, the color 
switches from blue to yellow.  
 Reagents and contents 
(MTP) are Microtiter Strips (in 1 strip holder), 8 well snap-off strips, 
ready for use coated with oxLDL. 
(TSP) is plate (in 1 strip holder, ready for use, coated with native 
LDL  
(CAL1 – CAL5) are 5×1 ml calibrators IgG IgM (white cap), human 
serum, inked according to concentration, ready for use  
1         12.5      U/ml 
2            25      U/ml 
3            50      U/ml 
4          100      U/ml 
5          200      U/ml 
Control (-) is 1ml negative control serum (green cap), human, ready 
for use  
Control (+) is 1ml positive control serum (red cap), human, ready for 
use concentrations are stated on the labels. 
(BUF) (WASH) (10×) WB03 are 50ml washing buffer (black cap) 
concentrate (10×) for about 0.51 phosphate buffer, pH 6.7 ± 0.2  
(DIL)  (DB16) are 100 ml dilution buffer (blue cap) ready for use, 
phosphate buffer pH 7.3 ± 0.2. 
(CONJ) (IgGM): HRP) are 12 ml conjugate solution (white cap) anti-
human-IgGM HRP conjugate, ready for use.  
(SUBS) (TMB) (TMB ELISA) is ml TMB solution (black cap) ready 
for use.  pH 3.7 ± 0.2, colorless to bluish. 3, 3`5, 5`-
tetramethylbenzidine 1.2 mmol/l, hydrogen peroxide 3mmol/l. 
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(SOLN) (STOP)(STOP ELISA) are 12 ml stop solution (red cap) 
sulphuric acid, ready for use 0.5 mol/l 1Pc adhesive strip. 
Procedure  
      
Hundred microliter diluted sample were pipetted, (CAL),(CONTROL 
+) and (CONTROL -) into (MTP) , for blank use (DIL) instead of 
sample dilution, seal (MTP) with (TSP). 
Then incubated for 1 hour at room temperature. 
let to dry for hour at room temperature and stored (TSP) in the 
lockable bag at 2-8 ˚C 
(MTP) worked using 250 µl (WASH) per well. Procedure repeated 3 
times.  
Buffers discarded and knock out residues on an absorbent paper or 
cloth.  
 Hundred microliter (CONJ) was pipetted (a (hum IgGM): HRP) and 
seal (MTP) with adhesive strip. 
Incubated for 30 min, at room temperature. 
(MTP) washed using 205 µl (WASH) per well. Procedure repeated 3 
times.  
Buffers discarded and knock out residues on an absorbent paper or 
cloth. 
Hundred microliter (SUBS) (TMB) were pipetted and incubated for 
10 min. At room temperatures above 25 ˚C. 
 Hundred microliter (SOLN) (STOP) were added per well.  
          Optical density was at 450 nm within the next 30 min after stopping 
           solution was added.          
 
2.1.9.1 Interpretation of result 
         Results above 30 U/m was considered. 
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2.1.10 Histopathological Method 
      The tissues were prepared for histopathological examination according 
to the method described by Bancroft (1996).  
Fixation 
     About one cubic centimeter of tissue showing lesion was fixed in 10% 
formal saline for preservation and fortifying the tissue. The fixation 
extended for at least three days.  
Tissue processing  
    The formalin fixed tissues were labeled and immersed into 70% alcohol. 
Dehydration 
       The dehydration of tissue is important to allow the paraffin to penetrate 
the tissue. The tissue was dehydrated by using different ascending grades of 
methanol (70% for two hours, 90% for two hours and in absolute alcohol for 
overnight).  
Clearing 
      The dehydrated tissue was removed by using chloroform for 18 hours.  
Embedding 
     The impregnated tissue was transferred to paraffin wax in melting point 
(54-56 ˚C) in moulds of suitable size then the blocks were allowed to cool 
and solidify.  
Microtomy  
     Microtomy of the embedded tissue was performed using a rotator 
microtome (Barried and Tatlock Ltd/. England). The produced sections were 
4-6 microns in thickness.  
Sections manipulation 
     The cut sections were fixed on a glass slides and dried at 37˚C for one 
hour.  
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Staining of sections  
      Before staining the sections, the tissues were freed off the wax using 
xylene and dehydrated the sections by different descending grades of 
methanol (100, 90and 70%). The tissues were then cleared with xylene and 
stained with Hematoxlin and Eosin (H&E) and dehydrated again by 
ascending grades methanol.  
Mounting 
     The stained sections were covered with glass cover slips, fixed by 
candada balsm and allowed to dry for 24 hours before examination.  
2.1.11 Statistical analysis 
       The means and standard error were obtained by using a computer 
statistical package named SPSS.        
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CHAPTER THREE 
THE RESULTS 
             
 3.1 Anti oxLDL immunoglobulins IgG and IgM production 
       Table (1) and figure (1) presents the production of antibodies, for all 
experimental groups of animals, after three months. The quantitative 
determination of anti-oxLDL antibodies IgG and IgM (u/ml) showed no 
significant difference between group B (Cholesterol treated) and group C 
(Saturated fat treated) compared to control group A (received normal rat 
diet). But only the group C received diet high in saturated fats showed 
significantly (P< 0.05) higher level compared to the other groups. 
 
Table (1) Anti oxLDL  immunoglobulins (IgG and IgM) concentration level 
after supplementation of 2% cholesterol (group B) and 14% saturated fats 
(Group C) compared to control (group A). 
                 Groups            
 
      Anti-oxLDL (IgG and IgM) u/ml  
   
 
Group A (control ) 
                                     a 
                   30.31  ±  0.47 
 
Group B (high cholesterol) 
                                          a 
                   30.18  ±  0.17 
 
Group C (high saturated fats) 
                                    b 
                   32.23  ±  1.37 
Means ± SE within the same column having different superscripts are 
significantly different at P< 0.05. 
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          Fig.(1)The level of anti oxLDL immunoglobulin IgG and IgM 
concentration in group (B) and group (C) compared to group (A) after 
supplementation of 2% cholesterol powder and 14% saturated fatty acid 
mixed with the basal diet respectively in rat. 
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3.2 Biochemical Parameters 
3.2.1 Serum Total Protein (STP) 
           Table 2 and figures 2  present the results of serum total protein for all 
groups of rats which showed significant (P< 0.05) increase in group B and 
group C compared to group A in the first and third month but in the second 
month there is no significant difference between group B compared to group 
A. No significant difference between group B and group C in first and third 
month, but there was significant (P<0.05) increase in group B compare to 
group C and group A in the second month.   
 
Table (2) Total serum protein level after supplementation of 2% cholesterol 
(group B) and 14% saturated fats (Group C). 
                                                   Serum total protein g/dl 
            Months      
 groups               
       1 
           
        2 
             
         3 
                
 
Group A 
                     a
5.74  ±  0.22 
                    a
6.87  ±  0.47 
                    a      
7.98  ±  0.25 
 
Group B 
                     b
7.82  ±  0.17 
                   a
7.85  ±  0.41 
                    b   
9.1   ±  0.19 
 
Group  C 
                     b   
7.98  ±  0.25 
                   b   
9.1   ±  0.19 
                     b
9.38  ±  0.11 
 
Means ± SE within the same column having different superscripts are 
significantly different at P< 0.05. 
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         Fig.(2) The level of total serum protein in group (B) and group (C) 
compared to group (A) after supplementation of 2% cholesterol powder and 
14% saturated fatty acid mixed with the basal diet respectively in rat. 
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3.2.2 Serum albumin  
           Table 3 and figure 3 present the results of serum albumin for all 
groups of rats which showed no significant difference between group B 
compared to group A during the three months. But significant (P<0.05) 
decrease in group C compared to group A the control group after the first 
and second month, but after the third month there was no significant 
difference between group C compared to group A. Also there was 
significant (P<0.05) increase of albumin in group C compared to group B 
and group A after the second month, but after the first month there was 
significant (P<0.05) decrease of albumin in group C compared to group B 
and group A. 
 
Table (3) Serum albumin level after supplementation of 2% cholesterol 
(group B) and 14% saturated fats (Group C). 
                                                      Serum albumin g/dl 
                      Month     
 groups   
       1 
           
        2 
             
         3 
                
 
Group A 
                    a 
4.65   ±  0.12 
                    a
4.37   ±   0.18 
    a
4.86   ±   0.25 
 
Group B 
                   a 
4.44  ±  0.22 
                    a 
4.81  ±  0.12 
                     a
4.85  ±  0.25 
 
Group  C 
                   b 
3.94  ±  0.19 
                    b 
 5.02  ±   0.18 
                     a  
4.67  ±   0.27 
 
Means ± SE within the same column having different superscripts are 
significantly different at P< 0.05. 
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         Fig.(3) The level of serum albumin in group (B) and group (C) 
compared to group (A) after supplementation of 2% cholesterol powder and 
14% saturated fatty acid mixed with the basal diet respectively in rat. 
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3.2.3 Serum Total globulin  
      Table 4 and figure 4 present the results of serum total globulins for all 
groups of rats which showed significant (P<0.05) increase in group B and C 
after first and third month compared to group A the control group, but there 
is no significant difference between the groups in the second month 
compared to group A. No significant difference between group B and group 
C during the period of experiment. 
 
Table (4) Serum total globulins level after supplementation of 2% 
cholesterol (group B) and 14% saturated fats (Group C). 
                                                     Serum globulin g/dl 
                      Months    
 groups   
       1 
           
        2 
             
         3 
                
 
Group A 
                     a   
1.74  ±  0.22 
                    a
2.41  ±  0.28 
                      a
3.24  ±  0.26 
 
Group B 
                     b
3.38  ±  0.17 
                     a
3.09  ±  0.42 
                      b
4.29  ±  0.23 
 
Group  C 
                     b
3.48  ±  0.14 
                     a
3.36  ±  0.29 
                      b
4.71  ±  0.22 
 
Means ± SE within the same column having different superscripts are 
significantly different at P< 0.05. 
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           Fig.(4) The level of serum total globulins in group (B) and group (C) 
compared to group (A) after supplementation of 2% cholesterol powder and 
14% saturated fatty acid mixed with the basal diet respectively in rat. 
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3.3 Hematological parameters  
3.3.1Differential count of lymphocytes 
Table 5 and figure 5 present the results of lymphocyte percentage for all 
groups of animal which showed no significant difference between group B 
and C compared to group A control group. No significant (P<0.05) 
difference between group B and group C after the second and third month.  
  
Table (5) lymphocytes count after supplementation of 2% cholesterol (group 
B) and 14% saturated fats (Group C). 
                                          Lymphocytes percentage (%)            
                      Months    
 Groups   
            2 
           
        3 
             
 
Group A 
                       a
63.5  ±  0.83            
                       a 
60.22  ±  1.54 
 
Group B 
                       a
65.13  ±  0.72 
                       a 
56.88  ±  7.59 
 
Group  C 
                       a
63.4   ±  0.64 
                      a  
61.9   ±  0.84 
 
Means ± SE within the same column having different superscripts are 
significantly different at P< 0.05. 
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          Fig.(5) The lymphocyte count in group (B) and group (C) compared 
to group (A) after supplementation of 2% cholesterol powder and 14% 
saturated fatty acid mixed with the basal diet respectively in rat. 
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3.3.2 Differential Count of Neutrophiles 
Table 6 and figure 6 the present the results of neutrophiles percentage for all 
groups of rats which showed significant (P<0.05) decrease in group B 
compare to C and A after third month. But no significant different between 
groups B and group C compare to group A after second month. 
   
Table (6) Neutrophiles count after supplementation of 2% cholesterol 
(group B) and 14% saturated fats (Group C). 
                                          Neutrophiles percentage (%)      
                      Months    
 Groups   
                2 
           
               3 
             
 
Group A 
                      a
27.2   ±  0.77 
                       a 
30.4   ±  1.26 
 
Group B 
                      a
26   ±  0.85 
                       b 
26.25  ±  1.16 
 
Group  C 
                       a
27.5   ±  0.62 
                       a 
27.1   ±  0.84 
 
Means ± SE within the same column having different superscripts are 
significantly different at P< 0.05. 
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           Fig.(6) The neutrophiles count in group (B) and group (C) compared 
to group (A) after supplementation of 2% cholesterol powder and 14% 
saturated fatty acid mixed with the basal diet respectively in rat. 
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3.3.3 Differential Count Eosinophiles  
Table 7 and figure 7 present the results of eosinophiles percentage for all 
groups of rats which showed no significant difference between group B and 
group C compared to group A control group. No significant difference 
between groups B compared to group C after the second and third month. 
  
Table (7) Eosinophiles count after supplementation of 2% cholesterol 
(group B) and 14% saturated fats (Group C). 
                                         Eosinophiles percentage        
                    Months     
 Groups   
                2 
           
                3 
             
 
Group A 
                     a
4.4  ±   0.22 
                    a 
4.1  ±  0.2 
 
Group B 
                      a
4.25  ±  0.45 
                     a 
4.64  ±  0.32 
 
Group  C 
                      a
4.1   ±  0.31 
                     a 
4.6   ±  0.31 
 
Means ± (SE) with in the same column having different superscript are 
significantly different at (P< 0.05). 
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        Fig.(7) The neutrophiles count in group (B) and group (C) compared to 
group (A) after supplementation of 2% cholesterol powder and 14% 
saturated fatty acid mixed with the basal diet respectively in rat. 
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3.3.4 Differential count monocytes 
Table 8 and figure 8 present the results of monocytes percentage for all 
groups of rats which no significant difference between group B and group C 
compared to group A. No significant difference in group B compared to 
group C after the second and third month. 
 
Table (8) Monocytes   count after supplementation of 2% cholesterol (group 
B) and 14% saturated fats (Group C). 
                                       Monocytes percentage (%)           
                    Months     
 Groups   
               2 
           
                  3 
             
 
Group A 
                    a
3.6  ±  0.31 
                   a 
3   ±  0.33 
 
Group B 
                    a
3.63  ±  0.26 
                    a 
3.13  ±  0.35 
 
Group  C 
                   a
4.2  ±   0.2 
                   a 
3.7  ±   0.37 
 
Means ± SE within the same column having different superscripts are 
significantly different at P< 0.05. 
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          Fig.(8) The monocytes count in group (B) and group (C) compared to 
group (A) after supplementation of 2% cholesterol powder and 14% 
saturated fatty acid mixed with the basal diet respectively in rat. 
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3.3.5 Differential count basophiles 
Table 9 and figure 9 present the results of basophiles percentage for all 
groups of rats showed no significant difference between group B and group 
C compared to group A. No significant (P<0.05) difference in group B 
compared to group C after the second and third month.  
 
Table (9) Basophiles count after supplementation of 2% cholesterol (group 
B) and 14% saturated fats (Group C). 
                                      Basophiles percentage (%)     
                    Months     
 Groups   
                2 
             
                3 
             
 
Group A 
                    a
1.3  ±  0.31 
                  a 
2   ±  0.24 
 
Group B 
                    a
1.23  ±  0.4 
                    a  
1.63  ±  0.32 
 
Group  C 
                   a
0.8  ±  0.3 
                  a 
2.2  ±  0.2 
 
Means ± SE within the same column having different superscripts are 
significantly different at P< 0.05. 
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        Fig.(9) The basophiles count in group (B) and group (C) compared to 
group (A) after supplementation of 2% cholesterol powder and 14% 
saturated fatty acid mixed with the basal diet respectively in rat. 
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3.3.6 Total count of white blood cells 
Table 10 and figure 10 present the results of total white blood cells count 
(per cubic millimeter) for all groups of rats showed no significant difference 
between group B and group C compared to group A control. No significant 
difference in group B compared to group C after second and third month.  
  
Table (10) Total white blood cells count after supplementation of 2% 
cholesterol (group B) and 14% saturated fats (Group C). 
                                      Total white blood cells  count         
                     Months     
 Groups   
                2 
           
                3 
             
 
Group A 
                           a
5130  ±  333.35 
                          a 
5300  ±  343.99 
 
Group B 
                           a
4500  ±  246.67 
                          a 
4750  ±  242.01 
 
Group  C 
                          a
4600  ±  132.49 
                          a 
4540  ±  146.21 
 
Means ± SE within the same column having different superscripts are 
significantly different at P< 0.05. 
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            Fig (10) the total white blood cells count in group (B) and group (C) 
compared to group (A) after supplementation of 2% cholesterol powder and 
14% saturated fatty acid mixed with the basal diet respectively in rat. 
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3.4 Histopathological Findings 
In group (B) which treated with cholesterol 2% for three months the 
heart showed edema of the cardiac muscles (fig.11) and zenker necrosis, 
hyalinization and there was increased thickness of the blood vessels (fig.12) 
and then was presence of cholesterol cleft (fig.13). 
              The liver in group (B) showed vacuolization (fig.14), dilatation of 
sinusoid, necrosis and disorganization of hepatocytes (fig.15). 
              In group (C) which treated with 14% saturated fats for three months 
heart showed hyalinization of cardiac muscles fiber (fig.16), edema and 
infiltration of RBCs in the heart muscle (fig.17). The wall of the blood vessels 
were thickened (fig.18).There is mild mononuclear cellular infiltration with 
zenker necrosis (fig.19). 
              The liver in group (C) showed vacuolization of hepatic cytoplasm, 
congestions of veins and dilatation of sinusoids (fig.20). Also there was bile 
duct proliferation (fig.21), kuffer cells were prominent (fig.22), and congestion 
of central veins and extra hepatic hemopoisis were evident (fig.23). In addition 
there was focal infiltration of inflammatory cells and necrosis. The control 
group presented healthy organs without inflammatory changes. 
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Fig (11): The cardiac muscle from  
rats  showed zenker necrosis (1) (2).     
 
Fig (12): Cardiac muscle from rats in 
group (B) showed increased thickness  
of blood vessels 
 
 
Fig (13): The heart from rats in group (B)  
showed cholesterol cleft. 
 
 
 
 
1
2 
 
The heart from rats in group (A) 
 
Heart section from rats in group 
(A) 
 
Heart section from rats in group (A) 
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Fig (14): The liver from rats in group  
(B) showed vacuolization. 
 
Fig (15): The liver from rats in group  
(B) notice sinusoid dilatation (1), necrosis   
(2) and disorganization of cells. 
  
Fig (16): Cardiac muscles fiber from  
rats in group (C) notice hyalinization  
and loss of nuclei. 
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Liver section from rats in group (A) 
 
Liver section from rats in group (A) 
 
Heart section from rats in group (A) 
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Fig (17): Heart muscle from rats in  
group (C) notice edema (1), necrosis(2) 
and infiltration of RBCs (3). 
 
 Fig (18): Cardiac muscles from rats  
in group (C) notice the wall of the  
blood vessels were thickened (1), zenker 
necrosis (2) and edema of muscles (3). 
 
Fig (19): Heart muscles from rats in  
group (C) notice the mild mononuclear 
 cellular infiltration (1) with zenker necrosis (2).  
1 
2 
3 
1 2 
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Heart section from rats in group (A) 
 
Heart section from rats in group (A) 
 
Heart section from rats in group (A)
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Fig (20): Liver from rats in group (C)  
showed vacuolization (1) and congestion (2).  
 
Fig (21): Liver from rats in group (C)  
notice bile duct proliferation. 
 
Fig (22): The liver from rats in group (C)  
showed prominent kuffer cells.  
2 
1
 
Liver section from rats in group (A) 
 
Liver section from rats in group (A) 
 
Liver section from rats in group (A) 
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Fig (23): liver from rats evident in group  
(C) notice congestion of central veins (1) 
and extra hepatic hemopoisis (2). 
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Liver section from rats in group (A) 
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CHAPTER FOUR 
DISSCUSIONS 
 
This study was carried out to evaluate the effect of feeding high 
cholesterol versus feeding saturated fats on plasma levels of total protein 
albumin, total globulins, anti-oxLDL IgG and IgM and differential and total 
count of white blood cells in Westar albino rats also to evaluate 
histopathological changes on heart and liver. 
4.1 The effect of feeding high cholesterol or high saturated fats           
diet on antibodies production level in rats 
4.1.1The anti-oxLDL immunoglobulin IgG and IgM production 
The results in the presentation showed that the concentration of anti-oxLDL 
antibodies IgG and IgM reported no significant differences between group B 
which fed 2% cholesterol powder mixed with the basal diet and group A the 
control group after 3 months. Group C which received 14% of saturated fats 
mixed in the basal diet showed signifantly (P< 0.05) higher level compared 
to the other groups. Friedman et al.( 1995) reported that circulating 
antibodies against ox-LDL which are  derived from cholesterol or saturated 
fats  are present in several inflammatory and autoimmune conditions. Such 
antibodies are also present in patients with atherosclerosis, although the 
pathogenic significance of the antibodies is still not known, but they are 
antibodies with regard to isotypes, subclass, affinity and effect on 
macrophage uptake of oxLDL. Also Forrester. (1995) reported that 
antibodies of IgG and IgM isotope were most common and found in both 
patients with atherosclerosis and in normal individuals. Both IgG and IgM 
antibodies have a high affinity for the antigen and increase the uptake of 
oxLDL from cholesterol or saturated fats. In the present study, the levels of 
the ox-LDL IgG and IgM were found to be signifantly (P< 0.05) higher in 
the group fed high saturated fats diet for three months compared to the other 
 61
 
 
groups this, finding may indicate that feeding saturated fats can results in 
atherosclerotic lesions more than feeding high cholesterol diet. Since 
Friedman. (1995) reported that both IgG and IgM antibodies have high 
affinity for the antigen and increase the uptake of ox-LDL in a monocyte 
like cell line, this can result in the formation of the atherosclerotic lesion as 
described by Maton. (1993) who explained that the body’s immune system 
responds to the damage to the artery wall caused by ox-LDL, by sending 
specialized white blood cells to absorb ox- LDL. Then they grow and 
rupture depositing greater amount of oxidized cholesterol into the artery 
wall. 
4.2The effect of feeding high cholesterol or high saturated fats            
diet on serum protein, albumin, globulin level in rats 
4.2.1 Serum total proteins (STP) 
            The present results of serum total protein of rats showed significant 
(P< 0.05) increase in group B and group C compared to group A after the 
first and third month, but after the second month there was no significant 
difference between group B compared to group A. Also there was 
significant (P<0.05) increase between group B compared to C after the 
second month only. These results are in agreement with a study provides 
strong additional support for the existence of a significant positive relation 
between concentrations of LDL, hypercholesterolemia and hyperlipidemia 
and the activity of cholesterol ester transfer protein (CETP) (Federico, 1995) 
which significant increase in plasma levels of the (CETP) in the present 
work  Also supports the concept that C - reactive protein (CRP) levels were 
significantly elevated in both cholesterol-fed and hyperlipidemia; CRP 
levels were clearly correlated with aortic atherosclerotic lesion size. 
Immunohistochemical revealed that CRP-immunoreactive proteins were    
found at all stages of atherosclerosis from the early to advanced lesions 
(Paterson, 2005). 
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 4.2.2 Serum albumin 
             The results of serum albumin of rats in the present work, showed 
significant (P<0.05) decrease in group C after first month compared to 
group A the control group, but there was significant (P<0.05) increase in 
group C compared to group B and A the control group after the second 
month. This result support the previous epidemiological studies which 
suggested that low levels of serum albumin are associated with an increased 
risk of CVD due to hypercholesterolemia and hyperlipidemia. It is not 
known whether low serum albumin is associated with early signs of 
atherosclerosis (Whitby, 1984). In contrast, some investigators have 
reported an inverse association between serum albumin and carotid 
atherosclerosis (Stein, 1999). However, in the present study the group fed 
high saturated fats diet reported significantly (P<0.05) lower levels after the 
first and the second months and numerically lower levels after three months 
compared to the other groups.  
4.2.3 Serum total globulins 
      The present results of serum total globulins showed significant (P<0.05) 
increase in group B and C after the first and the third months compared to 
group A the control group, but there is no significant difference between 
group B and C after second month compared to group A. Also there was no 
significant difference between group B and group C. This result supported 
studies that showed significant (P<0.05) increase of triglyceride and LDL 
cholesterol elevates globulin protein in a population with mild 
hypercholesterolemia (Fabricant, 1999).  
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4.3The effect of feeding high cholesterol diet or high saturated fats diet 
on differential count of white blood cells in rats 
4.3.1Lymphocyte 
        The present results of lymphocyte percentage of rats, showed no 
significant difference between group B and C compared to group A the 
control group. Also there was no significant difference between group B and 
group C after the second and the third months. This result showed that 
feeding high levels of saturated fats or high cholesterol diet for three months 
does not affect the levels of lymphocytes in the rats (Higley. 1996). In 
patients with peripheral artery disease not lymphocytes percentage indicated 
a substantially increased risk for major adverse cardiovascular events 
(Markus et al., 2005).  
4.3.2 Neutrophils 
The neutrophiles percentage of rats in this study showed only significantly 
(P<0.05) decrease in group B compared to A control and C after the second 
month. This result disagree which report of independent association of 
neutrophiles count with the angiographical characteristics of coronary 
atherosclerosis due to hypercholesterolemia and hyperlipidemia. In addition 
to, since activation of neutrophiles by triglycerides has been described in 
vitro, that hypothesized the postprandial there is a triglyceride-specific 
increase of neutrophiles counts and increased activation of monocytes and 
neutrophiles. This result is suggestive of a pro-inflammatory situation that 
may correspond with increased adhesive capacity of these cells contributing 
to the inflammatory component of atherosclerosis (Oamlmann, 2003). 
Activation of leukocytes is obligatory for inflammation and atherogenesis 
by adhering to the endothelium via specific ligands. There is a triglyceride 
(TG)-specific increase of neutrophiles counts and increased activation of 
monocytes and adhesive capacity of these cells contributing to the 
inflammatory component of atherosclerosis (Van Oostrom, 2004). It has 
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been hypothesized that higher neutrophiles percentage are associated with 
an increased incidence of major adverse cardiovascular events in patients 
with clinically advanced atherosclerosis. In patients with peripheral artery 
disease, only neutrophiles counts, but not eosinophiles, basophiles, 
monocytes, lymphocytes, or total WBC count indicated a substantially 
increased risk for major adverse cardiovascular events (Marku, 2005). 
4.3.3Eosinophiles 
      The present study eosinophiles percentage of rats which showed no 
significant differences after the second and the third months. Recently, it has 
been shown that only neutrophiles counts, but not eosinophiles indicated a 
substantially increased risk for major adverse cardiovascular events (Markus 
et al., 2005).  Esinophiles percentage   was not significantly different in 
control and cholesterol fed groups (Abdelhalim et al., 1994).  
4.3.4 Monocytes 
 The results of monocytes percentage of rats which showed no significant 
difference between the three groups. Also no significant difference in group 
B compared to group C after the second and the third months. The result of 
this study is a disagree that basal adherence of monocytes was significantly 
elevated in atherosclerosis, resulting in increased adherence to endothelial 
cells (Dovgan et al., 1994). Activation of leukocytes is obligatory for 
inflammation and atherogenesis by adhering to the endothelium via specific 
ligands. There is a triglyceride (TG)-specific increase activation of 
monocytes and adhesive capacity of these cells contributing to the 
inflammatory component of atherosclerosis (Van Oostrom et al. 2004).  
4.3.5 Basophiles 
The present results of basophiles percentage of rats showed no significant 
difference between group B and group C compared to group A the control 
group. Also no significant difference in group B compared to group C after 
the second and the third months. The result of this study is supported 
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conclusions that no basophiles associated with an increased incidence of 
major adverse cardiovascular events in patients with clinically advanced 
atherosclerosis (Markus, 2005).  
4.3.6Total count of white blood cells 
The total white blood cells count which showed no significant difference 
between groups B and group C compared to group A the control group. This 
result contrary that idea of dietary cholesterol increased blood total 
leucocytes count and induction of atherosclerotic plaques in the aorta and 
coronary arteries (Meijer et al., 1996). 
4.4 Histopathological Findings 
4.4.1 The effect of feeding high cholesterol diet or high saturated         
fats diet on heart tissues 
The heart samples in group fed 2% cholesterol (group B) when 
examined, showed zenker necrosis, hyalinization, edema of cardiac muscle, 
increased thickness of blood vessels and presence of cholesterol cleft. These 
findings are in agreement with the study of Ludwig et al. (1991) who 
reported that high dietary cholesterol in young rabbits caused an increase in 
intimal-plus-medial thickness from 0.31 mm and 0.33 mm to 0.88 mm and 
0.89 mm, respectively. Also the findings in the present study are in line with 
findings obtained by (Lutgens, 1999) who reported that mice fed high 
cholesterol develop atherosclerotic lesions resembling those found in 
humans, depending on their plasma cholesterol levels. Also in a study 
investigated whether the ACAT inhibitor can reduce atherogenesis 
independently of its cholesterol-lowering effect in Apo E 3-Leiden mice, 
before start this study, mice were fed high cholesterol diet for 3 weeks and 
reported accumulation of free cholesterol in atherosclerotic lesions (Dianne, 
2001). 
Whereas heart samples in the group fed 14% saturated fats (group C) 
showed hyalinization of cardiac muscles fiber, edema and infiltration of 
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RBCs in the heart muscle, the wall of the blood vessels were thickened and 
there is mild mononuclear cellular infiltration with zenker necrosis. These 
findings were in line with those obtained by Hans and Ruth (1973) who 
observed that some heart sections of rats fed saturated medium chain 
triglycerides, when stained with light green yellowish revealed areas of 
muscle fibrils that did not accept the stain, probably as a consequence of 
cellular damage.  
4.4.2 The effect of feeding high cholesterol diet or high saturated fats 
diet on liver 
The liver samples in the group fed 2% cholesterol (group B) 
showed vacuolization, dilatation of sinusoid, necrosis and disorganization of 
hepatocytes. These findings were in agreement with the study of (Wanless. 
1996) who said rabbits when given a cholesterol- supplemented diet (1%) 
developed sinusoidal and portal fibrosis lipid droplets in hepatocytes. Also 
these findings in the present work are in agreement with the study of 
(Hausner, 1995) that showed that cholesterol supplemented diet caused high 
plasma cholesterol level with hepatic cell degeneration. Also (Elaine,  1972) 
reported that histological examination of sections of livers showed fat 
infiltration of hepatic cells and a greater damage to the liver cells was noted 
when cholesterol was added to the basal diet of male rats. 
Hypercholesterolemia is said to contribute to hepatic injury as a result of 
cholesterol accumulation. Lack of underlying basement membranes 
facilitates the flow of LDL cholesterol in circulating plasma between 
sinusoidal lumen and hepatocytes, because in normal liver sinusoids are 
limited by fenestrated endothelial cells (Burt, 1993). The normal liver tissue 
has cholesterol oxidase. Cholesterol generates cholesterol oxidation 
products and free radicals by cholesterol oxidase. Cholesterol oxides include 
cytotoxic and steatotic effects (Aviram, 1992). Lipid accumulation leads to 
oxidative stress in hepatic tissue. The oxidative stress may contribute to 
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peroxidation of LDL. These peroxidative fatty acids and reactive oxygen 
species induce hepatic damage (Britton and Bacon, 1994). 
Whereas in the group fed 14% saturated fats (group C), showed 
vacuolization of hepatic cytoplasm, congestions of veins, dilatation of 
sinusoids, bile duct proliferation, kuffer cells were prominent, congestion of 
central veins and extra hepatic hemopoisis and focal infiltration of 
inflammatory cells and necrosis. These findings were in agreement with the 
study of (Ramachandran, 2006) who reported that when a computed diet 
based on cereals and spices incorporated with saturated fats fed to albino 
rats, histopathological examination of liver tissue in particular showed mild 
cytoplasmic vacuolation. Also Hans and Ruth (1973) found that when male 
rats fed saturated medium chain triglycerides, many livers revealed marked 
proliferation of bile ducts.  
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Conclusions and Recommendations 
 
Conclusions 
The results obtained from this work, indicated that high dietary 
saturated fats showed more clear and significant effects on plasma proteins 
compared to high dietary cholesterol, also group C presented higher levels 
of anti ox-LDL IgG and IgM antibodies compared to other group. On the 
other hand the histopathological findings indicated that’s both treated 
groups showed clear histopathological changes in liver and heart tissues. 
Recommendations 
• A study is recommended on the proinflammatory factors such as 
interleukin IL-6, IL-8 and complement component which have been 
postulated to play a role in the development of atherosclerosis. 
• Further detailed studies in the related cytokines together with change of 
the ox- LDL will give clear picture to explain these findings. 
• Total Cholesterol (TC), Low-Density Lipoprotein Cholesterol (LDL-C), 
High-Density Lipoprotein Cholesterol (HDL-C), triglyceride (TG), 
fibrinogen, haemoglobin, hematocrit, Red Blood Cells (RBC) and 
platelets are blood parameters that can help in diagnosis and monitoring 
the progression of atherosclerosis also these need more investigations. 
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